98/393/EC: Commission Decision of 19 May 1998 on financial assistance from the Community for storage in France, Italy and the United Kingdom of antigen for production of foot-and-mouth disease vaccine (notified under document number C(1998) 1365) (Only the English, French and Italian texts are authentic) (Text with EEA relevance)
Date: 1998-05-19
Institutions: European Commission
Subjects: EU Member State, EU aid, aid system, foot-and-mouth disease, storage, vaccine

20. 6. 98

‹

EN

‹

Official Journal of the European Communities

L 176/25

II

(Acts whose publication is not obligatory)

COMMISSION

COMMISSION DECISION

of 19 May 1998

on financial assistance from the Community for storage in France, Italy and the
United Kingdom of antigen for production of foot-and-mouth disease vaccine

(notified under document number C(1998) 1365)

(Only the English, French and Italian texts are authentic)

(Text with EEA relevance)

(98/393/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Decision 90/424/EEC of 26
June 1990 on expenditure in the veterinary field (1), as last
amended by Decision 94/370/EC (2), and in particular
Article 14 thereof,

Whereas by virtue of Council Decision 91/666/EEC of 11
December 1991 establishing Community reserves of foot-
and-mouth disease vaccines (3), establishment of antigen
banks
the Community’s action to create
Community reserves of foot-and-mouth disease vaccine;

is part of

Whereas the functions and duties of these antigen banks
that Decision; whereas
are specified in Article 4 of
Community assistance must be conditional on accom-
plishment of these;

Whereas Community financial
assistance should be
granted to these banks to enable them to carry out during
1998 the said functions and duties;

Whereas for budgetary reasons the Community assistance
should be granted for a period of one year;

Whereas for supervisory purposes Articles 8 and 9 of
Council Regulation (EEC) No 729/70 of 21 April 1970 on
financing of the common agricultural policy (4), as last
amended by Regulation (EC) No 1287/95 (5),
should
apply;

Whereas the measures provided for in this Decision are in
accordance with the opinion of the Standing Veterinary
Committee,

Whereas Article 3 of that Decision designates the ‘Labora-
toire de pathologie bovine du Centre national d’(cid:130)tudes
v(cid:130)t(cid:130)rinaires et alimentaires’ at Lyon in France, the ‘Istituto
Zooprofilattico Sperimentale die Brescia’ in Italy and the
‘Institute for Animal Health’ at Pirbright in the United
Kingdom as antigen banks holding Community reserves;

HAS ADOPTED THIS DECISION:

Article 1

1.
The Community shall grant France financial assis-
tance for the stocking of antigen for production of foot-
and-mouth disease vaccine.

(1) OJ L 224, 18. 8. 1990, p. 19.
(2) OJ L 168, 2. 7. 1994, p. 31.
(3) OJ L 368, 31. 12. 1991, p. 21.

(4) OJ L 94, 28. 4. 1970, p. 13.
(5) OJ L 125, 8. 6. 1995, p. 1.

L 176/26

‹

EN

‹

Official Journal of the European Communities

20. 6. 98

2.
The ‘Laboratoire de pathologie bovine du Centre
national d’(cid:130)tudes v(cid:130)t(cid:130)rinaires et alimentaires’ at Lyon in
France shall hold the stock of antigen to which paragraph
1 relates. The provisions of Article 4 of Decision
91/666/EEC shall apply.

3.
The Community’s financial assistance shall be a
maximum of ECU 40 000 for the period 1 January to 31
December 1998.

— 70 % by way of an advance at the request of the

Member State concerned,

— the balance following presentation, by the Member
supporting documents which

State concerned, of
demonstrate the effective completion of the tasks.

2.
The supporting documents referred to in paragraph
1 must be presented to the Commission before 1 March
1999 and they should include:

Article 2

(a) technical information on:

1.
The Community shall grant Italy financial assistance
for the stocking of antigen for production of foot-and-
mouth disease vaccine.

2.
The ‘Istituto Zooprofilattico Sperimentale di Brescia’
in Italy shall hold the stock of antigen to which para-
graph 1 relates. The provisions of Article 4 of Decision
91/666/EEC shall apply.

3.
The Community’s financial assistance shall be a
maximum of ECU 40 000 for the period 1 January to 31
December 1998.

Article 3

1.
The Community shall grant the United Kingdom
financial assistance for the stocking of antigen for produc-
tion of foot-and-mouth disease vaccine.

2.
The Institute for Animal Health at Pirbright in the
United Kingdom shall hold the stock of antigen to which
paragraph 1 relates. The provisions of Article 4 of De-
cision 91/666/EEC shall apply.

3.
The Community’s financial assistance shall be a
maximum of ECU 40 000 for the period 1 January to 31
December 1998.

Article 4

1.
The Community’s financial assistance referred to in
Article 1(3), Article 2(3) and Article 3(3) shall be paid as
follows:

— the amount and type of antigen stored (storage

records),

— storage equipment used (type, number and cap-

acity of tanks),

— security system in place (temperature control,

anti-theft measures),

— insurance arrangements (fire, accidents);

(b) financial information (completion of table as shown in

the Annex).

Article 5

Articles 8 and 9 of Regulation (EEC) No 729/70 shall
apply mutatis mutandis.

Article 6

This Decision is addressed to the French Republic, the
Italian Republic and the United Kingdom of Great
Britain and Northern Ireland.

Done at Brussels, 19 May 1998.

For the Commission

Franz FISCHLER

Member of the Commission

20. 6. 98

‹

EN

‹

Official Journal of the European Communities

L 176/27

ANNEX

Financial information related to the storage of antigen for production of foot-and-mouth disease
vaccine

STATEMENT OF COSTS

Reporting period from ................................................................... to ...................................................................

Reference No of Commission Decision providing financial assistance: ...........................................................

Name and address of beneficiary: .........................................................................................................................

....................................................................................................................................................................................

Category of costs

Amount for the period
(National currency) (1)

1. Staff

2. Capital equipment

3. Consumables

4. Insurance

5. Rental of premises

(1) All costs must be expressed in national currency.

Total

Certificate by the beneficiary

We certify that:

— the above costs were incurred in connection with the tasks defined in the Decision and were essential to

the sound performance of those tasks,

— they are genuine costs falling within the definition of reimbursable costs,

— all the documents supporting the costs are available for audit purposes.

Date: ...........................................................................................................................................................................

Name of technical director: ....................................................................................................................................

Signature: ...................................................................................................................................................................

Date: ...........................................................................................................................................................................

Person financially responsible: ................................................................................................................................

Signature: ...................................................................................................................................................................